Plus disease in retinopathy of prematurity qualitative analysis of diagnostic process by experts

JAMA Ophthalmology

Volumn 131, Issue 8, 2013, Pages 1026-1032

  Hewing, Nina J ^a,c   Kaufman, David R ^b   Chan, R V Paul ^a   Chiang, Michael F ^d,e  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b College of Physicians and Surgeons ^*  (United States)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC REASONING; HUMAN; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUALITATIVE RESEARCH; RETINA IMAGE; RETROLENTAL FIBROPLASIA; VIDEORECORDING;

DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; DILATATION, PATHOLOGIC; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; OBSERVER VARIATION; PHOTOGRAPHY; REPRODUCIBILITY OF RESULTS; RETINAL ARTERY; RETINAL VEIN; RETINOPATHY OF PREMATURITY; VIDEO RECORDING;

EID: 84881640446     PISSN: 21686165     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaophthalmol.2013.135     Document Type: Article

References (45)

1. International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity revisited [published comment appears in Arch Ophthalmol. 2006;124(11):1669-1670] . Arch Ophthalmol. 2005;123(7):991-999.
2. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity: Preliminary results. Arch Ophthalmol. 1988;106(4):471-479.
3. Early Treatment for Retinopathy of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: Results of the Early Treatment for Retinopathy of Prematurity randomized trial. Arch Ophthalmol. 2003;121(12): 1684-1694.
4. Mintz-Hittner HA, Kennedy KA, Chuang AZ; BEAT-ROP Cooperative Group. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med. 2011;364(7):603-615.
5. ChiangMF, Jiang L, Gelman R, Du YE, Flynn JT. Interexpert agreement of plus disease diagnosis in retinopathy of prematurity. Arch Ophthalmol. 2007;125(7):875-880.
6. Wallace DK, Quinn GE, Freedman SF, ChiangMF. Agreement among pediatric ophthalmologists in diagnosing plus and pre-plus disease in retinopathy of prematurity. J AAPOS. 2008;12(4):352-356.
7. Reynolds JD, Dobson V, Quinn GE, et al CRYO-ROP and LIGHT-ROP Cooperative Study Groups. Evidence-based screening criteria for retinopathy of prematurity: Natural history data from the CRYO-ROP and LIGHT-ROP studies. Arch Ophthalmol. 2002;120(11):1470-1476.
8. Gelman SK, Gelman R, Callahan AB, et al. Plus disease in retinopathy of prematurity: Quantitative analysis of standard published photograph. Arch Ophthalmol. 2010;128(9):1217-1220.
9. Rao R, Jonsson NJ, Ventura C, et al. Plus disease in retinopathy of prematurity: Diagnostic impact of field of view. Retina. 2012;32(6):1148-1155.
10. Thyparampil PJ, Park Y, Martinez-Perez ME, et al. Plus disease in retinopathy of prematurity: Quantitative analysis of vascular change. Am J Ophthalmol. 2010;150(4).
11. Ericsson KS, Simon HA. Protocol Analysis: Verbal Reports as Data. 2nd ed. Boston, MA: MIT Press; 1993.
12. Hassebrock F, Prietula M. A protocol-based scheme for the analysis of medical reasoning. Int J Man Mach Stud. 1992;37(5):613-652.doi:10.1016/0020- 7373(92)90026-H.
13. Cohen J.Weighted kappa: Nominal scale agreement with provision for scaled disagreement or partial credit. Psychol Bull. 1968;70(4):213-220.
14. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159-174.
15. Section on Ophthalmology American Academy of Pediatrics; American Academy of Ophthalmology; American Association for Pediatric Ophthalmology and Strabismus. Screening examination of premature infants for retinopathy of prematurity [published correction appears in Pediatrics. 2006;118(3):1324]. Pediatrics. 2006;117(2):572-576.
16. Wilkinson AR, Haines L, Head K, Fielder AR; Guideline Development Group of the Royal College of Paediatrics and Child Health; Royal College of Ophthalmologists; British Association of Perinatal Medicine. UK retinopathy of prematurity guideline. Eye (Lond). 2009;23(11):2137-2139.
17. Norman GR, Rosenthal D, Brooks LR, Allen SW, Muzzin LJ. The development of expertise in dermatology. Arch Dermatol. 1989;125(8): 1063-1068.
18. Crowley RS, Naus GJ, Stewart J III, Friedman CP. Development of visual diagnostic expertise in pathology: An information-processing study. J Am Med Inform Assoc. 2003;10(1):39-51.
19. Azevedo R, Faremo S, Lajoie SP. Expert-novice differences in mammogram interpretation. In: Trafton DSMJG, ed. Proceedings of the 29th Annual Cognitive Science Society; August 1-4, 2007; Nashville, TN.
20. Paul Chan RV,Williams SL, Yonekawa Y, Weissgold DJ, Lee TC, ChiangMF. Accuracy of retinopathy of prematurity diagnosis by retinal fellows. Retina. 2010;30(6):958-965.
21. Myung JS, Paul Chan RV, Espiritu MJ, et al. Accuracy of retinopathy of prematurity image-based diagnosis by pediatric ophthalmology fellows: Implications for training. J AAPOS. 2011;15(6):573-578.
22. Gelman R, Jiang L, Du YE, Martinez-Perez ME, Flynn JT, ChiangMF. Plus disease in retinopathy of prematurity: Pilot study of computer-based and expert diagnosis. J AAPOS. 2007;11(6):532-540.
23. Wallace DK, Freedman SF, Zhao Z, Jung SH. Accuracy of ROPtool vs individual examiners in assessing retinal vascular tortuosity. Arch Ophthalmol. 2007;125(11):1523-1530.
24. Wallace DK, Jomier J, Aylward SR, LandersMB III. Computer-automated quantification of plus disease in retinopathy of prematurity. J AAPOS. 2003;7(2):126-130.
25. Wallace DK, Freedman SF, Zhao Z. A pilot study using ROPtool to measure retinal vascular dilation. Retina. 2009;29(8):1182-1187.
26. Swanson C, Cocker KD, Parker KH, Moseley MJ, Fielder AR. Semiautomated computer analysis of vessel growth in preterm infants without and with ROP. Br J Ophthalmol. 2003;87(12):1474-1477.
27. Gelman R, Martinez-Perez ME, Vanderveen DK, Moskowitz A, Fulton AB. Diagnosis of plus disease in retinopathy of prematurity using Retinal Image multiScale Analysis. Invest Ophthalmol Vis Sci. 2005;46(12):4734-4738.
28. Koreen S, Gelman R, Martinez-Perez ME, et al. Evaluation of a computer-based system for plus disease diagnosis in retinopathy of prematurity. Ophthalmology. 2007;114(12):e59-e67.
29. Rabinowitz MP, Grunwald JE, Karp KA, Quinn GE, Ying GS, Mills MD. Progression to severe retinopathy predicted by retinal vessel diameter between 31 and 34 weeks of postconception age. Arch Ophthalmol. 2007;125(11):1495-1500.
30. Johnson KS,Mills MD, Karp KA, Grunwald JE. Semiautomated analysis of retinal vessel diameter in retinopathy of prematurity patients with and without plus disease. Am J Ophthalmol. 2007;143(4):723-725.
31. Wilson CM, Cocker KD, Moseley MJ, et al. Computerized analysis of retinal vessel width and tortuosity in premature infants. Invest Ophthalmol Vis Sci. 2008;49(8):3577-3585.
32. Shah DN, Karp KA, Ying GS, Mills MD, Quinn GE. Image analysis of posterior pole vessels identifies type 1 retinopathy of prematurity. J AAPOS. 2009;13(5):507-508.
33. Wallace DK, Zhao Z, Freedman SF. A pilot study using "ROPtool" to quantify plus disease in retinopathy of prematurity. J AAPOS. 2007;11(4): 381-387.
34. ChiangMF, Gelman R, Martinez-Perez ME, et al. Image analysis for retinopathy of prematurity diagnosis. J AAPOS. 2009;13(5):438-445.
35. ChiangMF, Gelman R, Williams SL, et al. Plus disease in retinopathy of prematurity: Development of composite images by quantification of expert opinion. Invest Ophthalmol Vis Sci. 2008;49(9): 4064-4070.
36. Ells AL, Holmes JM, Astle WF, et al. Telemedicine approach to screening for severe retinopathy of prematurity: A pilot study. Ophthalmology. 2003;110(11):2113-2117.
37. ChiangMF, Keenan JD, Starren J, et al. Accuracy and reliability of remote retinopathy of prematurity diagnosis. Arch Ophthalmol. 2006;124(3):322-327.
38. Wu C, Petersen RA, VanderVeen DK. RetCam imaging for retinopathy of prematurity screening. J AAPOS. 2006;10(2):107-111.
39. ChiangMF,Wang L, Busuioc M, et al. Telemedical retinopathy of prematurity diagnosis: Accuracy, reliability, and image quality. Arch Ophthalmol. 2007;125(11):1531-1538.
40. Scott KE, Kim DY,Wang L, et al. Telemedical diagnosis of retinopathy of prematurity intraphysician agreement between ophthalmoscopic examination and image-based interpretation. Ophthalmology. 2008;115(7): 1222-1228; e3.
41. Balasubramanian M, Capone A, HartnettME, et al; Photographic Screening for Retinopathy of Prematurity (Photo-ROP) Cooperative Group. The photographic screening for retinopathy of prematurity study (photo-ROP): Primary outcomes. Retina. 2008;28(3)(suppl):S47-S54.
42. Lorenz B, Spasovska K, Elflein H, Schneider N. Wide-field digital imaging based telemedicine for screening for acute retinopathy of prematurity (ROP): Six-year results of a multicentre field study. Graefes Arch Clin Exp Ophthalmol. 2009;247(9): 1251-1262.
43. Silva RA, Murakami Y, Lad EM, Moshfeghi DM. Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP): 36-month experience with telemedicine screening. Ophthalmic Surg Lasers Imaging. 2011;42(1):12-19.
44. Dai S, Chow K, Vincent A. Efficacy of wide-field digital retinal imaging for retinopathy of prematurity screening. Clin Experiment Ophthalmol. 2011;39(1):23-29.
45. Li AC, Kannry JL, Kushniruk A, et al. Integrating usability testing and think-aloud protocol analysis with "near-live" clinical simulations in evaluating clinical decision support. Int J Med Inform. 2012;81(11):761-772.